Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Pandemics and Biosecurity
9JUN

IHR committee meets, rejects travel bans

3 min read
09:58UTC

The expert panel Tedros bypassed to declare the emergency faster convened on 19 May and issued recommendations on 22 May: exit screening and tracing, and no travel or trade restrictions.

ScienceDeveloping
Key takeaway

The IHR committee's advice against travel bans is the codified 2014 lesson, not a discretionary preference.

The Emergency Committee under the International Health Regulations (IHR), the binding treaty governing cross-border outbreak response, convened on 19 May 1. This is the standing expert panel that Tedros Adhanom Ghebreyesus had bypassed when he declared the Bundibugyo emergency faster than procedure normally allows . Its Temporary Recommendations, issued 22 May, call for exit screening at borders, 21-day contact tracing and safe burials, and explicitly advise against travel or trade restrictions 2. The committee confirmed the emergency but stopped short of the higher Pandemic Emergency tier.

The 2005 IHR replaced cordon-style border closures with exit screening at source precisely because the West Africa Ebola response in 2014 showed that bans drive disease underground without stopping it: travellers hide their movements and slip in by other routes. By advising exit screening and against entry bans, the committee is enforcing the rule the regulations were rewritten to encode, not weighing options afresh.

That advice arrives into a contradiction. A 21-day entry ban from a major power was already in force when the recommendations published, which sets the committee's codified guidance directly against a member state's unilateral measure within the same week. The committee can recommend, but the IHR carries no enforcement teeth; its authority rests on reciprocity, the expectation that states follow shared rules because they need others to. When that breaks, the treaty's recommendations become advice a government can read and ignore.

Deep Analysis

In plain English

The IHR Emergency Committee is a panel of international disease experts that normally advises the WHO's director-general before a global health emergency is declared. This time, the WHO chief Tedros declared the emergency first (on 17 May) and only convened the committee afterwards, because the outbreak was growing fast and he had legal authority to act alone. The committee then met on 19 May and issued formal recommendations on 22 May. Those recommendations said countries should screen travellers at borders, trace contacts for three weeks if they have been near a case, and ensure safe burial practices to prevent further spread. The IHR committee explicitly advised against travel or trade bans from affected countries, on the grounds that bans drive affected people to informal crossing points where they cannot be screened. Travel bans push sick people away from official routes.

What could happen next?
  • Precedent

    Tedros's pre-committee PHEIC declaration sets a procedural precedent; future WHO directors-general may face pressure to declare faster in politically contested outbreaks, before the technical committee can provide cover for the decision.

  • Consequence

    The committee's no-travel-restriction advice, issued four days after the US entry ban was imposed, puts the United States formally in violation of IHR Temporary Recommendations with no legal enforcement mechanism to compel compliance.

First Reported In

Update #4 · Ebola triples, response misfires

World Health Organization· 24 May 2026
Read original
Different Perspectives
World Health Organization
World Health Organization
WHO's DON606 recalibration to confirmed-only reporting gives the clean baseline the CDC model rests on, but the apparent fall from 1,040 to 534 carries misinterpretation risk WHO communications have not pre-empted. The PABS deadlock ahead of IGWG7 and continuing MBP134/remdesivir assessment without authorisation make WHO the body most able to accelerate the two decisions that could change the outbreak's trajectory.
European Union (ECDC)
European Union (ECDC)
ECDC's Week 23 CDTR tracked four simultaneous non-Ebola signals: the Dermatophilus congolensis novel-transmission cluster across France, Germany and Spain; a 4.2-fold malaria surge in Mayotte; the Salmonella ST2045 multi-country cluster; and two new Saudi MERS cases. The continental early-warning layer is carrying a full multi-pathogen picture while Bundibugyo dominates headlines.
Uganda
Uganda
Uganda's 19 confirmed cases are concentrated in Kampala and Wakiso, an urban cluster that applied the 2022 Sudan-ebolavirus playbook; the Bwera border laboratory shortens cross-border confirmation to same-day. Uganda's regulatory authority must co-sign before MBP134 or remdesivir can dose any patient.
Democratic Republic of the Congo
Democratic Republic of the Congo
Kinshasa shares Bundibugyo sequence data in real time with no treaty-guaranteed access to the vaccines that data informs, and its health minister called the US entry ban discriminatory while negotiating an early lift. DRC accounts for 515 of 534 confirmed cases and faces IS-controlled access blockades in Mambasa that health authorities cannot resolve.
United States (HHS/CDC)
United States (HHS/CDC)
HHS expanded the Ebola entry ban to green-card holders on 5 June, widening a restriction expiring around 17 June against WHO advice. The CDC simultaneously published the R0=2.51 modelling, the sharpest analytical contribution to the response, from a federal bench that holds the NIH and acting CDC director roles in one person.
Imperial College London / Cori and Ferguson
Imperial College London / Cori and Ferguson
Anne Cori and Neil Ferguson place the case-fatality ratio at 30 to 40 per cent and read the 6.8-to-1 suspected-to-confirmed ratio as evidence that the laboratory figure understates true lethality. Many people die before a swab reaches them.